Clinical trials with ALS patients showed that riluzole gives a better chance of survival by several months , mainly in those with a hard time swallowing . Clinical trials with ALS patients showed that Riluzole lengthens survival by several months , and may have a greater survival benefit for those with a bulbar onset .